Stay updated on Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history now shows a site revision added (v3.3.2) and the previous revision (v3.2.0) removed. This reflects a maintenance update with no changes to study data or visible content.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the notice about government funding and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check34 days agoChange DetectedThis update appears to be a visual redesign of the page header and footer with no changes to the study record content or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedUpdated status notice and version to v3.2.0, replacing v3.1.0; added information about government funding lapse and operating status, and where to find details.SummaryDifference13%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check84 days agoChange DetectedOnly the revision tag changed from v3.0.1 to v3.0.2; no substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.